https://www.selleckchem.com/pr....oducts/epz005687.htm
Previous studies have shown conflicting observations regarding the correlation between sodium-glucose-cotransporter-2 inhibitors (SGLT2i) and acute renal failure. Although wide use has contributed to the accumulation of safety information on SGLT2i, the examination of the countries reporting cases of SGLT2i use and influence of concomitant drugs has been insufficient in studies using spontaneous adverse event reporting databases. We aimed to re-examine the correlation between SGLT2i and acute renal failure using the latest United Stat
Curtir
Comentario
Compartilhar
